The role of intrinsic fines in the performance change of expired lactose carriers for DPI applications.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 25 01 2022
revised: 18 04 2022
accepted: 18 04 2022
pubmed: 27 4 2022
medline: 26 5 2022
entrez: 26 4 2022
Statut: ppublish

Résumé

Dry powder inhalation offers a well-established administration route for either local or systemic drug delivery. Lactose-based powder blends still build the basis of respiratory drug delivery, despite of numerous emerging formulation approaches. The amount of fine lactose excipients, either extrinsic or intrinsic, crucially influences the aerodynamic performance of the corresponding blend. This study highlights the role of intrinsic fines as a fundamental performance affecting parameter during storage and expiry of lactose carrier bulk. We showed that intrinsic fines play an inferior role after expiring compared to fresh batches. If strongly adhering or even merged fines regain their mobility and contribute to the dispersion (by removal and re-addition), it will significantly enhance drug delivery. Furthermore, we provide evidence for decreased mobility of intrinsic fines caused by humidity (e.g., during inappropriate storage) resulting in decreased powder fluidisation.

Identifiants

pubmed: 35470067
pii: S0939-6411(22)00078-9
doi: 10.1016/j.ejpb.2022.04.006
pii:
doi:

Substances chimiques

Aerosols 0
Drug Carriers 0
Excipients 0
Powders 0
Lactose J2B2A4N98G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-12

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Nicholas Bungert (N)

Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.

Mirjam Kobler (M)

Meggle Excipients and Technology, Wasserburg, Germany.

Regina Scherließ (R)

Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany. Electronic address: rscherliess@pharmazie.uni-kiel.de.

Articles similaires

Aerosols Humans Decontamination Air Microbiology Masks
Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Calcium Carbonate Sand Powders Construction Materials Materials Testing

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Classifications MeSH